Cribstone Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $1.06M | Buy |
12,799
+506
| +4% | +$42K | 0.62% | 50 |
|
|
2022
Q3 | $975K | Sell |
12,293
-1,643
| -12% | -$130K | 0.6% | 48 |
|
|
2022
Q2 | $1.04M | Buy |
13,936
+787
| +6% | +$58.4K | 0.64% | 43 |
|
|
2022
Q1 | $1.18M | Buy |
13,149
+3,959
| +43% | +$356K | 0.65% | 45 |
|
|
2021
Q4 | $1.03M | Buy |
9,190
+859
| +10% | +$96.2K | 0.57% | 47 |
|
|
2021
Q3 | $1.05M | Buy |
8,331
+1,495
| +22% | +$188K | 0.62% | 42 |
|
|
2021
Q2 | $926K | Buy |
6,836
+245
| +4% | +$33.2K | 0.56% | 48 |
|
|
2021
Q1 | $894K | Buy |
6,591
+32
| +0.5% | +$4.34K | 0.59% | 48 |
|
|
2020
Q4 | $923K | Buy |
6,559
+16
| +0.2% | +$2.25K | 0.63% | 42 |
|
|
2020
Q3 | $729K | Sell |
6,543
-187
| -3% | -$20.8K | 0.6% | 48 |
|
|
2020
Q2 | $753K | Buy |
6,730
+190
| +3% | +$21.3K | 0.62% | 51 |
|
|
2020
Q1 | $506K | Buy |
6,540
+1,714
| +36% | +$133K | 0.54% | 53 |
|
|
2019
Q4 | $459K | Sell |
4,826
-1,440
| -23% | -$137K | 0.41% | 60 |
|
|
2019
Q3 | $478K | Sell |
6,266
-998
| -14% | -$76.1K | 0.29% | 69 |
|
|
2019
Q2 | $637K | Buy |
7,264
+1,798
| +33% | +$158K | 0.35% | 64 |
|
|
2019
Q1 | $495K | Buy |
+5,466
| New | +$495K | 0.26% | 75 |
|